日本Ｊａｎｓｓｅｎ Ｋｙｏｗａ,ＫｙｏｗａＨａｋｋｏ和Ｗｅｌｆｉｄｅ公司已经临时停止生产和销售胃动力药西沙必利 ,因该药对心脏有严重的副作用。随后决定撤消或限制在其他市场大量使用 ,但上述公司强调只要处方适当并按认可的剂量和标签用药 ,西沙必利仍然安全有效。日本 Japan’s Janssen Kyowa, Kyowa Sakko and Welfide have temporarily stopped production and sales of the stomach power drug cisapride, which has serious side effects on the heart. It was subsequently decided to withdraw or limit the mass use in other markets, but the companies emphasized that cisapride remains safe and effective as long as the prescriptions are properly administered and approved doses and labels. Japan